Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOCRATES-REDUCED: Vericiguat Dose Finding in Worsening HFrEF
NCT01951625Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 2 trial of vericiguat in heart failure with reduced ejection fraction (HFrEF), sponsored by Bayer. Started Nov 2013; status: completed.
02
Drugs
vericiguat
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT01951625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951625.